Formic Acid

Formic Acid

SCHEMBL29484057

NCCc1ccc(Cl)cc1.O=CO

nearest known ligand 0.75

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 7/20 0.75
▸ MAOB P27338 5/20 0.64
▸ HTR3A P46098 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ HTR1A P08908 1/20 0.50
▸ ADRA2A P08913 1/20 0.50
▸ SLC6A2 P23975 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ BACE1 P56817 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ BLM P54132 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ IDO1 P14902 2/20 0.47
▸ HTR3E A5X5Y0 1/20 0.46
▸ HTR3B O95264 1/20 0.46
▸ HTR3D Q70Z44 1/20 0.46
▸ HTR3C Q8WXA8 1/20 0.46
▸ PNMT P11086 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL232327 0.87 TAAR1 (1.00) TAAR1MAOBHTR3AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL10897947 0.84 TAAR1 (0.95) TAAR1MAOBHTR3AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL1924679 0.84 TAAR1 (0.95) TAAR1MAOBHTR3AKDM4EALDH1A1
Bromide SCHEMBL28684127 0.84 TAAR1 (0.95) TAAR1MAOBHTR3AKDM4EALDH1A1
Iodide SCHEMBL29127481 0.84 TAAR1 (0.95) TAAR1MAOBHTR3AKDM4EALDH1A1
SCHEMBL9468426 0.80 TAAR1 (0.86) TAAR1MAOBHTR3AKDM4EALDH1A1
Phenethylamine SCHEMBL27697034 0.78 HTR2A (0.73) TAAR1MAOBHTR3AKDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL29484054 0.77 TAAR1 (0.64) TAAR1MAOBHTR3AKDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL29484053 0.77 TAAR1 (0.64) TAAR1MAOBHTR3AKDM4EALDH1A1
SCHEMBL8351927 0.77 TAAR1 (0.78) TAAR1MAOBHTR3AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12612429-B2 Derivatives of dolaproine-dolaisoleuine peptides AGENSYS, INC. (US) 2026-04-28 — — US disclosed
US-20220204557-A1 DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES AGENSYS, INC. (US) 2022-06-30 — — US disclosed
US-11312748-B2 Derivatives of dolaproine-dolaisoleucine peptides AGENSYS, INC. (US) 2022-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204557-A1 DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES DDOST, VIP, THPO TAAR1 4857/4885MAOB 4627/4885HTR3A 4487/4885
US-12612429-B2 Derivatives of dolaproine-dolaisoleuine peptides DDOST, NGLY1, GRPR TAAR1 3642/4885MAOB 4617/4885HTR3A 4459/4885
US-11312748-B2 Derivatives of dolaproine-dolaisoleucine peptides VIP, DDOST, DNPEP TAAR1 4668/4885MAOB 4737/4885HTR3A 3833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback